Reopening of Black Sea a welcome relief, but while Ukraine remains volatile, latest data shows industry adapting
28.7.2022 10:44:00 EEST | Business Wire | Press release
With news of last week’s UN deal to reopen the Black Sea, allowing ocean grain shipments to resume from Ukraine, leading real-time supply chain visibility platform FourKites® released new data showing that agile shippers are finding ways of managing the volatile situation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220728005468/en/
FourKites data shows increased shipments to countries bordering Russia and Ukraine (Graphic: Business Wire)
Following Friday’s grain deal between Ukraine and Russia, FourKites expects grain shipments from Black Sea ports to resume within a few days. The same deal allows Russia to export fertiliser and other products not covered by international sanctions.
“My hope is that this agreement gives big shipping companies the confidence to resume operations in the region,” says Philippe Salles, FourKites’ VP Strategic Solutions (Ocean). “The next few weeks will be telling. But if things go well, this deal could be central to averting a worldwide food crisis. And despite the latest missile attack at the port of Odessa, indicating ongoing volatility in the region, our data indicates that shippers are well prepared for any contingency.”
Ukraine typically ships millions of tonnes of grain by ocean direct from its Black Sea ports to countries including Egypt, Indonesia and Bangladesh. The war effectively closed that route, as major shipping companies concluded it was too dangerous to operate in the Black Sea. Now, it is hoped, at least some of those shipments can resume.
“Our data for the last few weeks shows that logistics operators were already adapting to the situation in Ukraine,” says Salles. “Ukrainian shippers have been shifting to road and rail to move grain to sea ports outside the country, notably in Poland or via the Balkans to Adriatic ports such as Trieste and Rijeka.”
Shipments of all types to countries bordering Russia and Ukraine remain strong compared to the rest of Europe, where the 14-day average shipment volume is up 20% compared to 21 February, when the invasion began. At the same time, less than truckload (LTL) delays to Eastern Europe have decreased over the past few weeks, with delayed LTL shipments now only 15% higher than when the conflict began. This is down 48% month-on-month compared to mid-June, when LTL delays were as much as 33% higher than when the conflict began.
Prior to the UN deal, hundreds of thousands of tonnes of grain were destined to travel by longer land routes, which raised questions about whether there would be sufficient capacity to provide the thousands of additional truck journeys that would be needed.
“Ukrainian carriers are going full throttle to export grain and revive the country’s economic growth,” comments Maciej Mackowiak, FourKites’ Director, Carrier Marketing, Europe, who is based in Poland. “We are already seeing a lot of congestion on the Polish/Ukraine border because, since mid-July, the European Union has allowed Ukrainian road transport companies to make shipments without permits.”
Overall, moving goods into or out of Ukraine remains difficult. Shipment volumes to Ukraine have recovered slightly from their nadir in March, but are still 65% down on pre-war levels.
About FourKites
Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 200 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,000 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220728005468/en/
Contact information
Scott Johnston
European PR Director, FourKites
+31 62 147 8442
scott.johnston@fourkites.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 08:00:00 EEST | Press release
Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufacturing site. All other aspects of the BLA, including safety- and efficacy-related parts, did not solicit deficiencies to be addressed. The FDA made observations during the PLI for which Galderma is putting in place corrective and preventive actions. Galderma will also be seeking further guidance through continued open dialogue with the FDA toward resolution of the relevant observations. Galderma plans to rapidly respond to the CRL and advancing RelabotulinumtoxinA in the U.S. remains a top priority. The ob
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 04:45:00 EEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
